MENU

EVMN Evommune Inc. Forecast, Technical & Fundamental Analysis

Evommune Inc is a clinical-stage biotechnology company focused on creating new therapies aimed at key factors driving chronic inflammatory diseases... Show more

Interact to see
Advertisement
View a ticker or compare two or three
Interact to see
Advertisement
A.I. Advisor
published Earnings

EVMN is expected to report earnings to fall 7.87% to -81 cents per share on December 10

Evommune Inc. EVMN Stock Earnings Reports
Q3'26
Est.
$-0.82
Q2'26
Missed
by $0.20
Q1'26
Beat
by $0.12
The last earnings report on August 07 showed earnings per share of -88 cents, missing the estimate of -68 cents. With 589.51K shares outstanding, the current market capitalization sits at 241.34M.
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
ETFs / NAMEPrice $Chg $Chg %
SIXH45.150.04
+0.09%
ETC 6 Meridian Hedged Equity Index Option ETF (SIXH)
FDND20.75-0.06
-0.30%
FT Vest Dow Jones Internet & Target Income ETF (FDND)
MEM37.51-0.37
-0.98%
Matthews Emerging Markets Equity Active ETF (MEM)
EWC60.29-0.69
-1.13%
iShares MSCI Canada ETF (EWC)
PNI6.56-0.10
-1.50%
PIMCO NEW YORK Municipal Income FUND II
A.I. Advisor
published General Information

General Information

Industry Biotechnology

Industry
N/A
Address
1841 Page Mill Road
Phone
+1 925 247-4481
Employees
48
Web
https://www.evommune.com
Evommune (EVMN) stock Forecast, Price Targets and Analysts Predictions - Tickeron.com